Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / SPONSORED ADR
-
Total 13F shares
-
309,126,756
-
Share change
-
+112,024
-
Total reported value
-
$11,909,339,872
-
Put/Call ratio
-
55%
-
Price per share
-
$38.50
-
Number of holders
-
869
-
Value change
-
-$23,346,819
-
Number of buys
-
366
-
Number of sells
-
387
Institutional Holders of GSK plc - SPONSORED ADR (GSK) as of Q2 2024
As of 30 Jun 2024,
GSK plc - SPONSORED ADR (GSK) was held by
869 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
309,126,756 shares.
The largest 10 holders included
Dodge & Cox, FMR LLC, JTC Employer Solutions Trustee Ltd, Fisher Asset Management, LLC, PRIMECAP MANAGEMENT CO/CA/, PRICE T ROWE ASSOCIATES INC /MD/, MORGAN STANLEY, Royal Bank of Canada, STATE STREET CORP, and Holocene Advisors, LP.
This page lists
871
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.